Senior Principal Scientist, HTS AstraZeneca R&D UK, Discovery Sciences, Hit Discovery, England, United Kingdom
Instructors will be presenting virtually. Laptop will be required to access the course.
Additional Fees Apply -- visit the Short Course Program section for more information.
This short course will provide an introduction to mass spectrometry and the range of potential applications within drug discovery. We will cover the basic principles of mass spectrometry including the differences between the array of ionization modalities and detectors available today. While mass spectrometry has contributed significantly to drug discovery, recent advances are enabling high throughput screening applications.
Who Should Attend:
Lab scientists with an interest in understanding the fundamentals of mass spectrometry
Lab managers interested in understanding how mass spectrometry can impact drug discovery
Budget holders who are considering investing in mass spectrometry technology
Assay development scientists and HTS screeners who want to understand how mass spectrometry can impact their research
How You Will Benefit From This Course:
Get a better understanding of the principles of mass spectrometry
Gain an understanding of the diversity of instruments and ionization techniques
Understanding of where mass spectrometry can be applied with impact in drug discovery
Learn about recent developments in mass spectrometry
Course Topics:
Overview of the most relevant biochemical biophysics/ label-free technologies for screening and lead finding.
Main technologies discussed in more detail: Mass Spectrometry; NMR; Calorimetry (DSC, ITC); SPR; Interferometry; Resonance Waveguide Grating (aka Corning Epic); thermal protein denaturation and aggregation assays (DSF aka Thermofluor, DSLS aka Stargazer, CETSA; nanoDSF); Dynamic Light Scattering; Microscale Thermophoresis (NanoTemper).
Understand which technology and combinations thereof fits best to answer specific questions throughout the entire drug discovery process.
Grasp how biophysics can support assay development for screening and how biophysical data can be used to fuel medicinal chemistry design.
Course Pre-Reading Requirements:
General introduction into affinity-based methods and their application in Drug Discovery: (articles which describe how the approaches work, caveats, and a summary of their impact)
Integrating biophysics with HTS-driven drug discovery projects Folmer, Rutger H.A. Drug Discovery Today, March 2016, Vol.21(3), pp.491-498 Identifier: ISSN: 1359-6446 ; DOI: 10.1016/j.drudis.2016.01.011
Applications of Biophysics in High-Throughput Screening Hit Validation Genick, Christine Clougherty ; Barlier, Danielle ; Monna, Dominique ; Brunner, Reto ; Bé, Céline ; Scheufler, Clemens ; Ottl, Johannes Journal of biomolecular screening, June 2014, Vol.19(5), pp.707-14 Identifier: E-ISSN: 1552-454X ; PMID: 24695619 Version:1 ; DOI: 10.1177/1087057114529462
Biophysics in Drug Discovery: impact, challenges, and opportunities, Jean-Paul Renaud, Chun wa Chung, U. Helena Danielson, Ursula Egner, Michael Hennig, Roderick E. Hubbard, and Herbert Nar Nature Reviews, August 2016, Vol.15(10), pp. 679-98 DOI: 10.1038/nrd.2016.123
Background Information on each technology/approach:
DLS: Making sense of Brownian motion: colloid characterization by dynamic light scattering Hassan, Puthusserickal A ; Rana, Suman ; Verma, Gunjan Langmuir: the ACS journal of surfaces and colloids, 13 January 2015, Vol.31(1), pp.3-12 Identifier: E-ISSN: 1520-5827 ; PMID: 25050712 Version:1 DOI: 10.1021/la501789z
TSA: Thermal denaturation assays in chemical biology Senisterra, Guillermo ; Chau, Irene ; Vedadi, Masoud Assay and drug development technologies, April 2012, Vol.10(2), pp.128-36 Identifier: E-ISSN: 1557-8127 ; PMID: 22066913 Version:1 DOI: 10.1089/adt.2011.0390
CETSA: The cellular thermal shift assay for evaluating drug target interactions in cells Jafari, Rozbeh ; Almqvist, Helena ; Axelsson, Hanna ; Ignatushchenko, Marina ; Lundbäck, Thomas ; Nordlund, Pär ; Martinez Molina, Daniel Nature protocols, September 2014, Vol.9(9), pp.2100-22 Identifier: E-ISSN: 1750-2799 ; PMID: 25101824 Version:1 DOI: 10.1038/nprot.2014.138
MST: Microscale Thermophoresis: Interaction analysis and beyond Jerabek-Willemsen, Moran ; André, Timon ; Wanner, Randy ; Roth, Heide Marie ; Duhr, Stefan ; Baaske, Philipp ; Breitsprecher, Dennis Journal of Molecular Structure, 5 December 2014, Vol.1077, pp.101-113 Identifier: ISSN: 0022-2860 ; DOI: 10.1016/j.molstruc.2014.03.009
MS: Affinity selection-mass spectrometry screening techniques for small molecule drug discovery Annis, D. Allen ; Nickbarg, Elliot ; Yang, Xianshu ; Ziebell, Michael R. ; Whitehurst, Charles E. Current Opinion in Chemical Biology, 2007, Vol.11(5), pp.518-526
NMR: Parallel screening of low molecular weight fragment libraries: do differences in methodology affect hit identification? Wielens, Jerome ; Headey, Stephen J ; Rhodes, David I ; Mulder, Roger J ; Dolezal, Olan ; Deadman, John J ; Newman, Janet ; Chalmers, David K ; Parker, Michael W ; Peat, Thomas S ; Scanlon, Martin J Journal of biomolecular screening, February 2013, Vol.18(2), pp.147-59 Identifier: E-ISSN: 1552-454X ; PMID: 23139382 Version:1 DOI: 10.1177/1087057112465979
SPR: Biomolecular interaction analysis in drug discovery using surface plasmon resonance technology Huber, W ; Mueller, F Current Pharmaceutical Design, 2006, Vol.12(31), pp.3999-4021 Identifier: ISSN: 1381-6128
ITC: Direct measurement of protein binding energetics by isothermal titration calorimetry Leavitt, Stephanie ; Freire, Ernesto Current Opinion in Structural Biology, 2001, Vol.11(5), pp.560-566 Identifier: ISSN: 0959-440X ; DOI: 10.1016/S0959-440X(00)00248-7
Xray: Effective and Emerging Strategies for utilizing Structure in Drug Discovery Brown, Ka ; Davenport, R ; Ward, Se Drugs Of The Future, 2015 Apr, Vol.40(4), pp.251-256 [Peer Reviewed Journal] Identifier: ISSN: 0377-8282 ; DOI: 10.1358/dof.2015.040.04.2314768